Company / Capital Expenditures
Bio-Techne Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$31.0M
FY2025
5-year range
$25.4M / $62.9M
FY2021-FY2025
Trend
-50.7%
vs FY2024
Sector context
#96 of 151
Health Care
What the data says
At $31M, Bio-Techne's capital expenditures ranks #96 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $15M in FY2017 to $63M in FY2024.
Based on SEC 10-K filings.
$31M in FY2025 with a 5-year CAGR of -9.7%.
Declined from $44M to $31M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -15.7%
- 5-Year CAGR
- -9.7%
- 10-Year CAGR
- -
Sector benchmark
#96 of 151 in Health CareTop 64% of 151This company $31.0M Sector average $271.7M
▼
-88.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -9.7%, indicating a declining trend.
- In FY2025, capital expenditures decreased 50.7% year-over-year.
- Ranks #96 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.0M | -50.7% |
| FY2024 | $62.9M | +41.9% |
| FY2023 | $44.3M | -14.4% |
| FY2022 | $51.7M | +103.6% |
| FY2021 | $25.4M | -50.9% |
| FY2020 | $51.7M | +103.6% |
| FY2019 | $25.4M | +21.4% |
| FY2018 | $20.9M | +37.9% |
| FY2017 | $15.2M | -10.2% |
| FY2016 | $16.9M | -15.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026